Indian indices surge on crude oil relief, Sensex gains 544 points
Indian benchmark indices rallied on Monday as easing crude oil prices, driven by renewed US-Iran talks, lifted investor sentiment across the market. The Sensex gained 544 points and the Nifty rose 1.6%, adding nearly Rs 5 lakh crore to BSE market capitalisation, with TCS and IndiGo among top gainers.
Indian equities extended gains on Monday, buoyed by a decline in crude oil prices following reports of renewed dialogue between the United States and Iran. According to market reports, the Sensex advanced 544 points while the Nifty 50 climbed 1.6%, reflecting broad-based strength across sectors. The rally added approximately Rs 5 lakh crore to the BSE's overall market capitalisation. Among the day's movers, TCS, IndiGo, and Infosys emerged as top gainers, while Sun Pharma and Apollo Hospitals lagged behind their peers, suggesting divergent sector performance within the benchmark indices.
The easing of crude oil prices holds particular significance for Indian equities, as the country remains a net importer of petroleum products. Lower oil prices typically reduce input costs for energy-dependent sectors and ease inflationary pressures, supporting corporate profitability and consumer purchasing power. This dynamic particularly benefits sectors such as aviation, consumer discretionary, and chemicals, where energy comprises a material cost component. The indication of renewed US-Iran negotiations signals potential relief from geopolitical tensions that have historically driven oil volatility. For equity traders and portfolio managers, crude oil price movements serve as a key barometer for inflation trends and monetary policy expectations, making Monday's rally a reflection of improved macro sentiment driven by external geopolitical developments rather than domestic factors.
Source: Markets-Economic Times
This article is an editorial summary sourced from third-party news providers and is produced by marketkin.com for informational purposes only. It does not constitute investment advice. Disclaimer